Penn study discovers a targetable vulnerability in clear cell renal cell carcinoma

By | August 10, 2021
Clear cell renal cell carcinoma (ccRCC) cells can be destroyed and kept from multiplying by inhibiting the HDL cholesterol receptor SCARB1, according to research from the Perelman School of Medicine at the University of Pennsylvania.